Quest Diagnostics Incorporated has received $1.19 as the consensus Earnings Estimate for the Quarter ending on Mar 2017 ,According to the estimate provided by 12 Financial Advisor in the Stock Trading Firms. Among 12 Analysts, Bottom line EPS Estimate for the current quarter is $1.15 while the top line estimate is $1.26 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 5.88%.
Quest Diagnostics Incorporated reported better than expected with a surprise EPS of 3.15% or $0.04 during its most recent quarterly earnings. The Actual EPS was $1.31 compared to the Estimated EPS of $1.27. Madison based Quest Diagnostics Incorporated Last reported the Quarter results on Dec 31, 2016 and the Next earnings date is scheduled to be released on Apr 20, 2017.
Quest Diagnostics Incorporated has a Price to Earnings ratio of 17.61 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 2.69. For the Most Recent Fiscal Year, Quest Diagnostics Incorporated has a price to cash ratio of 13.48. For the Trailing twelve month period, company showed a Net Profit Margin of 8.56% and Return on Equity of the stock is 14.61%.
In the last quarter, Quest Diagnostics Incorporated reported Annual Earnings of $1.31. Based on the filings, last years Annual Earnings was, $5.15. In the last Quarter, DGX reported a surprise Earnings per Share of 3.15% . The consensus estimate for current quarter is $1.19 and for the current fiscal year, the estimate is $5.44. For the Next fiscal year, the estimate is $5.75 based on the consensus.
Quest Diagnostics Incorporated (NYSE:DGX) : On Tuesday heightened volatility was witnessed in Quest Diagnostics Incorporated (NYSE:DGX) which led to swings in the share price. The stock opened for trading at $90.68 and hit $91.95 on the upside , eventually ending the session at $91.92, with a gain of 1.52% or 1.38 points. The heightened volatility saw the trading volume jump to 1,384,275 shares. The 52-week high of the share price is $95.14 and the company has a market cap of $12,593 million. The 52-week low of the share price is at $59.655 .
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.